https://www.selleckchem.com/products/r428.html
© 2020 Wiley-VCH Verlag GmbH Co. KGaA, Weinheim.While cochlear implantation (CI) technology has greatly improved over the past 40 years, one aspect of CI that continues to pose difficulties is the variability of outcomes due to numerous factors involved in postimplantation performance. The electric acoustic stimulation (EAS) system has expanded indications for CI to include patients with residual hearing, and is currently becoming a standard therapy for these patients. Genetic disorders are known to be the most common cause of congen
Like
Comment
Share
